GO:0097159 | organic cyclic compound binding | 51.09% (47/92) | 1.04 | 0.0 | 8.6e-05 |
GO:1901363 | heterocyclic compound binding | 51.09% (47/92) | 1.05 | 0.0 | 0.000137 |
GO:0005488 | binding | 76.09% (70/92) | 0.6 | 0.0 | 0.000262 |
GO:0097367 | carbohydrate derivative binding | 21.74% (20/92) | 1.66 | 4e-06 | 0.000881 |
GO:0012501 | programmed cell death | 11.96% (11/92) | 2.51 | 4e-06 | 0.000952 |
GO:0032991 | protein-containing complex | 30.43% (28/92) | 1.3 | 4e-06 | 0.001039 |
GO:0000166 | nucleotide binding | 27.17% (25/92) | 1.42 | 3e-06 | 0.001058 |
GO:1901265 | nucleoside phosphate binding | 27.17% (25/92) | 1.42 | 3e-06 | 0.001058 |
GO:0032989 | cellular component morphogenesis | 6.52% (6/92) | 3.95 | 3e-06 | 0.00111 |
GO:1901564 | organonitrogen compound metabolic process | 42.39% (39/92) | 0.96 | 7e-06 | 0.001232 |
GO:0030554 | adenyl nucleotide binding | 19.57% (18/92) | 1.82 | 3e-06 | 0.001236 |
GO:0003674 | molecular_function | 81.52% (75/92) | 0.45 | 7e-06 | 0.001239 |
GO:0060255 | regulation of macromolecule metabolic process | 34.78% (32/92) | 1.14 | 6e-06 | 0.001275 |
GO:0036094 | small molecule binding | 29.35% (27/92) | 1.39 | 2e-06 | 0.001293 |
GO:0051247 | positive regulation of protein metabolic process | 13.04% (12/92) | 2.27 | 7e-06 | 0.001309 |
GO:0009987 | cellular process | 75.0% (69/92) | 0.52 | 6e-06 | 0.001314 |
GO:0003713 | transcription coactivator activity | 6.52% (6/92) | 3.66 | 8e-06 | 0.00134 |
GO:0032559 | adenyl ribonucleotide binding | 19.57% (18/92) | 1.83 | 2e-06 | 0.00138 |
GO:0048519 | negative regulation of biological process | 33.7% (31/92) | 1.13 | 1e-05 | 0.001475 |
GO:0033554 | cellular response to stress | 25.0% (23/92) | 1.4 | 1.1e-05 | 0.001547 |
GO:0051716 | cellular response to stimulus | 32.61% (30/92) | 1.15 | 1.2e-05 | 0.001611 |
GO:0048513 | animal organ development | 13.04% (12/92) | 2.2 | 1.1e-05 | 0.001615 |
GO:0008289 | lipid binding | 9.78% (9/92) | 2.65 | 1.4e-05 | 0.001711 |
GO:0043170 | macromolecule metabolic process | 42.39% (39/92) | 0.92 | 1.4e-05 | 0.001758 |
GO:0008219 | cell death | 11.96% (11/92) | 2.28 | 1.7e-05 | 0.001766 |
GO:0006807 | nitrogen compound metabolic process | 48.91% (45/92) | 0.81 | 1.6e-05 | 0.001796 |
GO:0005575 | cellular_component | 81.52% (75/92) | 0.42 | 1.9e-05 | 0.0018 |
GO:0019538 | protein metabolic process | 30.43% (28/92) | 1.18 | 1.8e-05 | 0.001807 |
GO:0032555 | purine ribonucleotide binding | 19.57% (18/92) | 1.62 | 1.7e-05 | 0.001827 |
GO:0017076 | purine nucleotide binding | 19.57% (18/92) | 1.62 | 1.8e-05 | 0.00185 |
GO:0043168 | anion binding | 22.83% (21/92) | 1.43 | 2.2e-05 | 0.001956 |
GO:0002082 | regulation of oxidative phosphorylation | 3.26% (3/92) | 5.79 | 2.2e-05 | 0.001984 |
GO:0006661 | phosphatidylinositol biosynthetic process | 4.35% (4/92) | 4.58 | 2.5e-05 | 0.002073 |
GO:0050877 | nervous system process | 7.61% (7/92) | 3.03 | 2.5e-05 | 0.002073 |
GO:0032553 | ribonucleotide binding | 19.57% (18/92) | 1.59 | 2.4e-05 | 0.002076 |
GO:0032990 | cell part morphogenesis | 5.43% (5/92) | 3.83 | 2.8e-05 | 0.002241 |
GO:0045087 | innate immune response | 11.96% (11/92) | 2.19 | 3e-05 | 0.002281 |
GO:1902494 | catalytic complex | 16.3% (15/92) | 1.75 | 3.6e-05 | 0.002723 |
GO:0044403 | biological process involved in symbiotic interaction | 10.87% (10/92) | 2.26 | 4.6e-05 | 0.003353 |
GO:0048523 | negative regulation of cellular process | 26.09% (24/92) | 1.22 | 5.6e-05 | 0.003391 |
GO:0051702 | biological process involved in interaction with symbiont | 8.7% (8/92) | 2.6 | 5.5e-05 | 0.003432 |
GO:0043067 | regulation of programmed cell death | 11.96% (11/92) | 2.08 | 5.8e-05 | 0.003433 |
GO:0007400 | neuroblast fate determination | 2.17% (2/92) | 7.41 | 5.5e-05 | 0.003452 |
GO:0016360 | sensory organ precursor cell fate determination | 2.17% (2/92) | 7.41 | 5.5e-05 | 0.003452 |
GO:0042478 | regulation of eye photoreceptor cell development | 2.17% (2/92) | 7.41 | 5.5e-05 | 0.003452 |
GO:0045314 | regulation of compound eye photoreceptor development | 2.17% (2/92) | 7.41 | 5.5e-05 | 0.003452 |
GO:0010468 | regulation of gene expression | 28.26% (26/92) | 1.14 | 6.3e-05 | 0.003491 |
GO:0005524 | ATP binding | 16.3% (15/92) | 1.67 | 6.4e-05 | 0.00352 |
GO:0010941 | regulation of cell death | 13.04% (12/92) | 1.95 | 6.1e-05 | 0.003527 |
GO:0006955 | immune response | 11.96% (11/92) | 2.07 | 6.2e-05 | 0.003544 |
GO:0034641 | cellular nitrogen compound metabolic process | 29.35% (27/92) | 1.11 | 6.6e-05 | 0.003565 |
GO:1905368 | peptidase complex | 4.35% (4/92) | 4.3 | 5.3e-05 | 0.003748 |
GO:0019222 | regulation of metabolic process | 36.96% (34/92) | 0.94 | 5.4e-05 | 0.003759 |
GO:0008150 | biological_process | 80.43% (74/92) | 0.39 | 7.7e-05 | 0.004006 |
GO:0050789 | regulation of biological process | 53.26% (49/92) | 0.67 | 7.7e-05 | 0.004068 |
GO:0030849 | autosome | 2.17% (2/92) | 7.15 | 8.2e-05 | 0.004155 |
GO:0006520 | cellular amino acid metabolic process | 9.78% (9/92) | 2.31 | 8.5e-05 | 0.004271 |
GO:0032501 | multicellular organismal process | 34.78% (32/92) | 0.95 | 9.1e-05 | 0.004446 |
GO:1903715 | regulation of aerobic respiration | 3.26% (3/92) | 5.07 | 0.0001 | 0.004759 |
GO:0044238 | primary metabolic process | 51.09% (47/92) | 0.68 | 9.9e-05 | 0.004783 |
GO:0070176 | DRM complex | 2.17% (2/92) | 6.92 | 0.000114 | 0.005245 |
GO:0009605 | response to external stimulus | 36.96% (34/92) | 0.89 | 0.000112 | 0.005247 |
GO:0044260 | cellular macromolecule metabolic process | 21.74% (20/92) | 1.31 | 0.000117 | 0.005292 |
GO:0043228 | non-membrane-bounded organelle | 21.74% (20/92) | 1.3 | 0.000129 | 0.005334 |
GO:0043232 | intracellular non-membrane-bounded organelle | 21.74% (20/92) | 1.3 | 0.000129 | 0.005334 |
GO:0046854 | phosphatidylinositol phosphate biosynthetic process | 3.26% (3/92) | 4.96 | 0.000126 | 0.005358 |
GO:0003712 | transcription coregulator activity | 7.61% (7/92) | 2.66 | 0.000125 | 0.00538 |
GO:0043409 | negative regulation of MAPK cascade | 4.35% (4/92) | 3.99 | 0.000123 | 0.005398 |
GO:0046488 | phosphatidylinositol metabolic process | 4.35% (4/92) | 3.99 | 0.000123 | 0.005398 |
GO:0048583 | regulation of response to stimulus | 28.26% (26/92) | 1.06 | 0.000159 | 0.005601 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 6.52% (6/92) | 2.91 | 0.000158 | 0.005612 |
GO:0051246 | regulation of protein metabolic process | 16.3% (15/92) | 1.56 | 0.000157 | 0.005666 |
GO:0035203 | regulation of lamellocyte differentiation | 2.17% (2/92) | 6.73 | 0.000152 | 0.005697 |
GO:0035204 | negative regulation of lamellocyte differentiation | 2.17% (2/92) | 6.73 | 0.000152 | 0.005697 |
GO:0045611 | negative regulation of hemocyte differentiation | 2.17% (2/92) | 6.73 | 0.000152 | 0.005697 |
GO:0045613 | regulation of plasmatocyte differentiation | 2.17% (2/92) | 6.73 | 0.000152 | 0.005697 |
GO:0045614 | negative regulation of plasmatocyte differentiation | 2.17% (2/92) | 6.73 | 0.000152 | 0.005697 |
GO:0060582 | cell fate determination involved in pattern specification | 2.17% (2/92) | 6.73 | 0.000152 | 0.005697 |
GO:0009626 | plant-type hypersensitive response | 7.61% (7/92) | 2.61 | 0.000157 | 0.005736 |
GO:0034050 | programmed cell death induced by symbiont | 7.61% (7/92) | 2.61 | 0.000157 | 0.005736 |
GO:0044248 | cellular catabolic process | 18.48% (17/92) | 1.42 | 0.000169 | 0.005782 |
GO:0071897 | DNA biosynthetic process | 4.35% (4/92) | 3.87 | 0.000168 | 0.005842 |
GO:1901565 | organonitrogen compound catabolic process | 11.96% (11/92) | 1.93 | 0.000147 | 0.005973 |
GO:0050896 | response to stimulus | 57.61% (53/92) | 0.57 | 0.000187 | 0.006262 |
GO:0007346 | regulation of mitotic cell cycle | 7.61% (7/92) | 2.57 | 0.000187 | 0.006333 |
GO:0003676 | nucleic acid binding | 29.35% (27/92) | 1.01 | 0.0002 | 0.006468 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 13.04% (12/92) | 1.77 | 0.000195 | 0.006473 |
GO:0045017 | glycerolipid biosynthetic process | 5.43% (5/92) | 3.24 | 0.000198 | 0.006477 |
GO:0022402 | cell cycle process | 13.04% (12/92) | 1.77 | 0.000203 | 0.00649 |
GO:0051603 | proteolysis involved in protein catabolic process | 9.78% (9/92) | 2.14 | 0.000213 | 0.006748 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 19.57% (18/92) | 1.33 | 0.00023 | 0.006973 |
GO:0006950 | response to stress | 45.65% (42/92) | 0.71 | 0.000225 | 0.006979 |
GO:0000502 | proteasome complex | 3.26% (3/92) | 4.67 | 0.000228 | 0.00699 |
GO:0006996 | organelle organization | 19.57% (18/92) | 1.33 | 0.000237 | 0.007023 |
GO:0048522 | positive regulation of cellular process | 28.26% (26/92) | 1.03 | 0.000225 | 0.007026 |
GO:0009056 | catabolic process | 20.65% (19/92) | 1.28 | 0.000236 | 0.007078 |
GO:0048584 | positive regulation of response to stimulus | 17.39% (16/92) | 1.42 | 0.000269 | 0.007432 |
GO:1901000 | regulation of response to salt stress | 6.52% (6/92) | 2.77 | 0.000267 | 0.007451 |
GO:0007610 | behavior | 6.52% (6/92) | 2.77 | 0.000267 | 0.007451 |
GO:0019752 | carboxylic acid metabolic process | 16.3% (15/92) | 1.49 | 0.000256 | 0.007517 |
GO:0043069 | negative regulation of programmed cell death | 7.61% (7/92) | 2.47 | 0.000278 | 0.007542 |
GO:0043167 | ion binding | 33.7% (31/92) | 0.89 | 0.00026 | 0.007552 |
GO:0016020 | membrane | 45.65% (42/92) | 0.7 | 0.000266 | 0.007574 |
GO:0046486 | glycerolipid metabolic process | 6.52% (6/92) | 2.75 | 0.000282 | 0.007588 |
GO:0005654 | nucleoplasm | 14.13% (13/92) | 1.63 | 0.000277 | 0.007599 |
GO:0003008 | system process | 8.7% (8/92) | 2.27 | 0.000265 | 0.007615 |
GO:0035639 | purine ribonucleoside triphosphate binding | 16.3% (15/92) | 1.47 | 0.000297 | 0.00777 |
GO:0048812 | neuron projection morphogenesis | 4.35% (4/92) | 3.66 | 0.000292 | 0.007775 |
GO:0046532 | regulation of photoreceptor cell differentiation | 2.17% (2/92) | 6.27 | 0.000297 | 0.007838 |
GO:1905369 | endopeptidase complex | 3.26% (3/92) | 4.53 | 0.000303 | 0.007843 |
GO:0048858 | cell projection morphogenesis | 4.35% (4/92) | 3.64 | 0.000309 | 0.007858 |
GO:0120039 | plasma membrane bounded cell projection morphogenesis | 4.35% (4/92) | 3.64 | 0.000309 | 0.007858 |
GO:0006650 | glycerophospholipid metabolic process | 5.43% (5/92) | 3.09 | 0.000321 | 0.008102 |
GO:0008270 | zinc ion binding | 8.7% (8/92) | 2.22 | 0.00034 | 0.008497 |
GO:0042981 | regulation of apoptotic process | 8.7% (8/92) | 2.21 | 0.000346 | 0.008577 |
GO:0043457 | regulation of cellular respiration | 3.26% (3/92) | 4.46 | 0.000354 | 0.008703 |
GO:0043169 | cation binding | 23.91% (22/92) | 1.11 | 0.000359 | 0.008727 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 6.52% (6/92) | 2.68 | 0.000371 | 0.008956 |
GO:0098542 | defense response to other organism | 23.91% (22/92) | 1.1 | 0.000396 | 0.009479 |
GO:0009653 | anatomical structure morphogenesis | 20.65% (19/92) | 1.21 | 0.000416 | 0.009489 |
GO:0035770 | ribonucleoprotein granule | 6.52% (6/92) | 2.65 | 0.000402 | 0.00953 |
GO:0006508 | proteolysis | 11.96% (11/92) | 1.75 | 0.000415 | 0.009542 |
GO:1901981 | phosphatidylinositol phosphate binding | 4.35% (4/92) | 3.53 | 0.000415 | 0.009608 |
GO:0110165 | cellular anatomical entity | 77.17% (71/92) | 0.36 | 0.000426 | 0.009635 |
GO:0065007 | biological regulation | 54.35% (50/92) | 0.57 | 0.000415 | 0.009678 |
GO:0009893 | positive regulation of metabolic process | 21.74% (20/92) | 1.17 | 0.000413 | 0.009724 |
GO:0005515 | protein binding | 55.43% (51/92) | 0.55 | 0.000461 | 0.010344 |
GO:0010038 | response to metal ion | 13.04% (12/92) | 1.63 | 0.00047 | 0.010464 |
GO:0031401 | positive regulation of protein modification process | 7.61% (7/92) | 2.35 | 0.000474 | 0.010473 |
GO:0031325 | positive regulation of cellular metabolic process | 19.57% (18/92) | 1.24 | 0.00049 | 0.010734 |
GO:0046474 | glycerophospholipid biosynthetic process | 4.35% (4/92) | 3.45 | 0.000507 | 0.01077 |
GO:0007611 | learning or memory | 4.35% (4/92) | 3.45 | 0.000507 | 0.01077 |
GO:0044419 | biological process involved in interspecies interaction between organisms | 29.35% (27/92) | 0.93 | 0.000504 | 0.010873 |
GO:0051171 | regulation of nitrogen compound metabolic process | 28.26% (26/92) | 0.96 | 0.000501 | 0.010894 |
GO:1903828 | negative regulation of protein localization | 4.35% (4/92) | 3.45 | 0.000519 | 0.010952 |
GO:0004812 | aminoacyl-tRNA ligase activity | 3.26% (3/92) | 4.23 | 0.000566 | 0.011042 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.26% (3/92) | 4.23 | 0.000566 | 0.011042 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3.26% (3/92) | 4.23 | 0.000566 | 0.011042 |
GO:0098800 | inner mitochondrial membrane protein complex | 4.35% (4/92) | 3.44 | 0.000532 | 0.011136 |
GO:0106371 | fluorescent chlorophyll catabolite monooxygenase (deformylase) activity | 2.17% (2/92) | 5.82 | 0.000564 | 0.011233 |
GO:0036444 | calcium import into the mitochondrion | 2.17% (2/92) | 5.82 | 0.000564 | 0.011233 |
GO:0007307 | eggshell chorion gene amplification | 2.17% (2/92) | 5.82 | 0.000564 | 0.011233 |
GO:0010235 | guard mother cell cytokinesis | 2.17% (2/92) | 5.82 | 0.000564 | 0.011233 |
GO:0010375 | stomatal complex patterning | 2.17% (2/92) | 5.82 | 0.000564 | 0.011233 |
GO:0007409 | axonogenesis | 3.26% (3/92) | 4.25 | 0.000542 | 0.011267 |
GO:0050794 | regulation of cellular process | 45.65% (42/92) | 0.65 | 0.000592 | 0.011306 |
GO:1901987 | regulation of cell cycle phase transition | 6.52% (6/92) | 2.55 | 0.000584 | 0.011321 |
GO:0008340 | determination of adult lifespan | 4.35% (4/92) | 3.39 | 0.000598 | 0.011357 |
GO:0048518 | positive regulation of biological process | 31.52% (29/92) | 0.87 | 0.000603 | 0.011366 |
GO:0050905 | neuromuscular process | 3.26% (3/92) | 4.21 | 0.000591 | 0.011368 |
GO:0010604 | positive regulation of macromolecule metabolic process | 19.57% (18/92) | 1.22 | 0.000559 | 0.01153 |
GO:0050885 | neuromuscular process controlling balance | 2.17% (2/92) | 5.73 | 0.000644 | 0.011675 |
GO:0006277 | DNA amplification | 2.17% (2/92) | 5.73 | 0.000644 | 0.011675 |
GO:0120025 | plasma membrane bounded cell projection | 10.87% (10/92) | 1.79 | 0.000628 | 0.011773 |
GO:0007062 | sister chromatid cohesion | 3.26% (3/92) | 4.17 | 0.000642 | 0.011801 |
GO:0007613 | memory | 3.26% (3/92) | 4.17 | 0.000642 | 0.011801 |
GO:0043038 | amino acid activation | 3.26% (3/92) | 4.15 | 0.000669 | 0.011909 |
GO:0043039 | tRNA aminoacylation | 3.26% (3/92) | 4.15 | 0.000669 | 0.011909 |
GO:0017053 | transcription repressor complex | 3.26% (3/92) | 4.15 | 0.000669 | 0.011909 |
GO:0050890 | cognition | 4.35% (4/92) | 3.36 | 0.000641 | 0.011927 |
GO:0046872 | metal ion binding | 22.83% (21/92) | 1.08 | 0.000688 | 0.012169 |
GO:0045931 | positive regulation of mitotic cell cycle | 4.35% (4/92) | 3.33 | 0.000701 | 0.012319 |
GO:0043066 | negative regulation of apoptotic process | 6.52% (6/92) | 2.5 | 0.000705 | 0.012322 |
GO:0047484 | regulation of response to osmotic stress | 6.52% (6/92) | 2.49 | 0.000738 | 0.012821 |
GO:0030163 | protein catabolic process | 7.61% (7/92) | 2.23 | 0.000748 | 0.012825 |
GO:0140513 | nuclear protein-containing complex | 11.96% (11/92) | 1.65 | 0.000744 | 0.01284 |
GO:0051707 | response to other organism | 28.26% (26/92) | 0.92 | 0.000766 | 0.012986 |
GO:0009266 | response to temperature stimulus | 16.3% (15/92) | 1.34 | 0.000766 | 0.013059 |
GO:0010499 | proteasomal ubiquitin-independent protein catabolic process | 2.17% (2/92) | 5.56 | 0.000818 | 0.013625 |
GO:0016504 | peptidase activator activity | 2.17% (2/92) | 5.56 | 0.000818 | 0.013625 |
GO:0007422 | peripheral nervous system development | 2.17% (2/92) | 5.56 | 0.000818 | 0.013625 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 3.26% (3/92) | 4.03 | 0.000845 | 0.013988 |
GO:0060548 | negative regulation of cell death | 7.61% (7/92) | 2.2 | 0.000865 | 0.014152 |
GO:0080134 | regulation of response to stress | 18.48% (17/92) | 1.22 | 0.000862 | 0.014191 |
GO:0005829 | cytosol | 27.17% (25/92) | 0.93 | 0.000878 | 0.014287 |
GO:0003958 | NADPH-hemoprotein reductase activity | 2.17% (2/92) | 5.48 | 0.000913 | 0.014689 |
GO:0034982 | mitochondrial protein processing | 2.17% (2/92) | 5.48 | 0.000913 | 0.014689 |
GO:0010562 | positive regulation of phosphorus metabolic process | 5.43% (5/92) | 2.74 | 0.000966 | 0.015037 |
GO:0045937 | positive regulation of phosphate metabolic process | 5.43% (5/92) | 2.74 | 0.000966 | 0.015037 |
GO:0043207 | response to external biotic stimulus | 29.35% (27/92) | 0.87 | 0.000952 | 0.015059 |
GO:0140657 | ATP-dependent activity | 8.7% (8/92) | 1.99 | 0.000959 | 0.015085 |
GO:0009967 | positive regulation of signal transduction | 9.78% (9/92) | 1.84 | 0.000946 | 0.015129 |
GO:0006952 | defense response | 26.09% (24/92) | 0.95 | 0.000951 | 0.015136 |
GO:0033304 | chlorophyll a metabolic process | 2.17% (2/92) | 5.41 | 0.001013 | 0.015343 |
GO:0033310 | chlorophyll a catabolic process | 2.17% (2/92) | 5.41 | 0.001013 | 0.015343 |
GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 2.17% (2/92) | 5.41 | 0.001013 | 0.015343 |
GO:0090571 | RNA polymerase II transcription repressor complex | 2.17% (2/92) | 5.41 | 0.001013 | 0.015343 |
GO:0032502 | developmental process | 42.39% (39/92) | 0.65 | 0.001024 | 0.015436 |
GO:0009892 | negative regulation of metabolic process | 18.48% (17/92) | 1.2 | 0.001004 | 0.015536 |
GO:0071704 | organic substance metabolic process | 53.26% (49/92) | 0.53 | 0.001075 | 0.016109 |
GO:0002376 | immune system process | 13.04% (12/92) | 1.49 | 0.0011 | 0.016322 |
GO:0051301 | cell division | 7.61% (7/92) | 2.14 | 0.001095 | 0.016325 |
GO:0005667 | transcription regulator complex | 5.43% (5/92) | 2.69 | 0.001123 | 0.016401 |
GO:0007007 | inner mitochondrial membrane organization | 2.17% (2/92) | 5.34 | 0.001118 | 0.016408 |
GO:0051560 | mitochondrial calcium ion homeostasis | 2.17% (2/92) | 5.34 | 0.001118 | 0.016408 |
GO:0042995 | cell projection | 10.87% (10/92) | 1.67 | 0.001184 | 0.017122 |
GO:1901575 | organic substance catabolic process | 17.39% (16/92) | 1.22 | 0.001181 | 0.017165 |
GO:0009416 | response to light stimulus | 17.39% (16/92) | 1.22 | 0.001207 | 0.017362 |
GO:0009607 | response to biotic stimulus | 29.35% (27/92) | 0.85 | 0.001232 | 0.017367 |
GO:0002922 | positive regulation of humoral immune response | 2.17% (2/92) | 5.27 | 0.001228 | 0.017394 |
GO:0007498 | mesoderm development | 2.17% (2/92) | 5.27 | 0.001228 | 0.017394 |
GO:0031399 | regulation of protein modification process | 9.78% (9/92) | 1.78 | 0.001251 | 0.01747 |
GO:0031323 | regulation of cellular metabolic process | 29.35% (27/92) | 0.85 | 0.001247 | 0.01749 |
GO:0048869 | cellular developmental process | 17.39% (16/92) | 1.22 | 0.001225 | 0.017525 |
GO:0043436 | oxoacid metabolic process | 16.3% (15/92) | 1.26 | 0.001312 | 0.018226 |
GO:0007616 | long-term memory | 2.17% (2/92) | 5.21 | 0.001342 | 0.018381 |
GO:0045610 | regulation of hemocyte differentiation | 2.17% (2/92) | 5.21 | 0.001342 | 0.018381 |
GO:0035091 | phosphatidylinositol binding | 4.35% (4/92) | 3.07 | 0.001356 | 0.018484 |
GO:0080090 | regulation of primary metabolic process | 28.26% (26/92) | 0.86 | 0.001339 | 0.018519 |
GO:2001138 | regulation of phospholipid transport | 2.17% (2/92) | 5.15 | 0.001462 | 0.019643 |
GO:2001140 | positive regulation of phospholipid transport | 2.17% (2/92) | 5.15 | 0.001462 | 0.019643 |
GO:0016307 | phosphatidylinositol phosphate kinase activity | 2.17% (2/92) | 5.15 | 0.001462 | 0.019643 |
GO:0046685 | response to arsenic-containing substance | 3.26% (3/92) | 3.73 | 0.001539 | 0.020577 |
GO:0071243 | cellular response to arsenic-containing substance | 2.17% (2/92) | 5.09 | 0.001587 | 0.020924 |
GO:0001891 | phagocytic cup | 2.17% (2/92) | 5.09 | 0.001587 | 0.020924 |
GO:0046483 | heterocycle metabolic process | 25.0% (23/92) | 0.92 | 0.001578 | 0.020998 |
GO:0023056 | positive regulation of signaling | 9.78% (9/92) | 1.73 | 0.001614 | 0.021179 |
GO:0008152 | metabolic process | 55.43% (51/92) | 0.48 | 0.00164 | 0.021427 |
GO:0019395 | fatty acid oxidation | 3.26% (3/92) | 3.69 | 0.001681 | 0.021858 |
GO:1903047 | mitotic cell cycle process | 7.61% (7/92) | 2.03 | 0.001698 | 0.021986 |
GO:0005543 | phospholipid binding | 5.43% (5/92) | 2.55 | 0.001707 | 0.021999 |
GO:0010647 | positive regulation of cell communication | 9.78% (9/92) | 1.71 | 0.001752 | 0.022472 |
GO:0030100 | regulation of endocytosis | 4.35% (4/92) | 2.97 | 0.001763 | 0.02251 |
GO:0051130 | positive regulation of cellular component organization | 7.61% (7/92) | 2.01 | 0.001793 | 0.022589 |
GO:0044270 | cellular nitrogen compound catabolic process | 6.52% (6/92) | 2.24 | 0.001786 | 0.022606 |
GO:0008266 | poly(U) RNA binding | 3.26% (3/92) | 3.66 | 0.00178 | 0.022629 |
GO:0046700 | heterocycle catabolic process | 6.52% (6/92) | 2.23 | 0.001819 | 0.022825 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 2.17% (2/92) | 4.98 | 0.001851 | 0.023122 |
GO:0010498 | proteasomal protein catabolic process | 6.52% (6/92) | 2.2 | 0.001993 | 0.023266 |
GO:0023051 | regulation of signaling | 17.39% (16/92) | 1.16 | 0.001876 | 0.023328 |
GO:0080135 | regulation of cellular response to stress | 7.61% (7/92) | 1.99 | 0.001993 | 0.023358 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 13.04% (12/92) | 1.39 | 0.001992 | 0.023442 |
GO:0010646 | regulation of cell communication | 17.39% (16/92) | 1.15 | 0.002019 | 0.023465 |
GO:0019054 | modulation by virus of host cellular process | 2.17% (2/92) | 4.92 | 0.00199 | 0.023521 |
GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor | 2.17% (2/92) | 4.92 | 0.00199 | 0.023521 |
GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 2.17% (2/92) | 4.92 | 0.00199 | 0.023521 |
GO:0030317 | flagellated sperm motility | 2.17% (2/92) | 4.92 | 0.00199 | 0.023521 |
GO:0060285 | cilium-dependent cell motility | 2.17% (2/92) | 4.92 | 0.00199 | 0.023521 |
GO:0060294 | cilium movement involved in cell motility | 2.17% (2/92) | 4.92 | 0.00199 | 0.023521 |
GO:0097722 | sperm motility | 2.17% (2/92) | 4.92 | 0.00199 | 0.023521 |
GO:0044237 | cellular metabolic process | 48.91% (45/92) | 0.53 | 0.00205 | 0.023632 |
GO:0045807 | positive regulation of endocytosis | 3.26% (3/92) | 3.59 | 0.002043 | 0.023652 |
GO:0036211 | protein modification process | 20.65% (19/92) | 1.02 | 0.002074 | 0.023815 |
GO:0016032 | viral process | 4.35% (4/92) | 2.9 | 0.002109 | 0.023932 |
GO:0045664 | regulation of neuron differentiation | 3.26% (3/92) | 3.62 | 0.001935 | 0.02396 |
GO:0009314 | response to radiation | 17.39% (16/92) | 1.15 | 0.001946 | 0.023993 |
GO:0045787 | positive regulation of cell cycle | 5.43% (5/92) | 2.48 | 0.002107 | 0.023999 |
GO:1903008 | organelle disassembly | 3.26% (3/92) | 3.57 | 0.002098 | 0.024001 |
GO:0044068 | modulation by symbiont of host cellular process | 2.17% (2/92) | 4.87 | 0.002135 | 0.024124 |
GO:0008187 | poly-pyrimidine tract binding | 3.26% (3/92) | 3.6 | 0.001989 | 0.024202 |
GO:0007423 | sensory organ development | 3.26% (3/92) | 3.6 | 0.001989 | 0.024202 |
GO:0048639 | positive regulation of developmental growth | 4.35% (4/92) | 2.92 | 0.001978 | 0.024283 |
GO:0098796 | membrane protein complex | 7.61% (7/92) | 1.96 | 0.002194 | 0.024702 |
GO:0031334 | positive regulation of protein-containing complex assembly | 3.26% (3/92) | 3.55 | 0.002212 | 0.024704 |
GO:0000911 | cytokinesis by cell plate formation | 3.26% (3/92) | 3.55 | 0.002212 | 0.024704 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 2.17% (2/92) | 4.82 | 0.002284 | 0.024918 |
GO:1904376 | negative regulation of protein localization to cell periphery | 2.17% (2/92) | 4.82 | 0.002284 | 0.024918 |
GO:0007164 | establishment of tissue polarity | 2.17% (2/92) | 4.82 | 0.002284 | 0.024918 |
GO:0001539 | cilium or flagellum-dependent cell motility | 2.17% (2/92) | 4.82 | 0.002284 | 0.024918 |
GO:0043632 | modification-dependent macromolecule catabolic process | 7.61% (7/92) | 1.95 | 0.002276 | 0.025221 |
GO:0006082 | organic acid metabolic process | 16.3% (15/92) | 1.18 | 0.002272 | 0.025271 |
GO:1990762 | cytoplasmic alanyl-tRNA aminoacylation | 1.09% (1/92) | 8.73 | 0.002354 | 0.025391 |
GO:0042158 | lipoprotein biosynthetic process | 1.09% (1/92) | 8.73 | 0.002354 | 0.025391 |
GO:0006422 | aspartyl-tRNA aminoacylation | 1.09% (1/92) | 8.73 | 0.002354 | 0.025391 |
GO:0002920 | regulation of humoral immune response | 2.17% (2/92) | 4.78 | 0.002437 | 0.025426 |
GO:0007476 | imaginal disc-derived wing morphogenesis | 2.17% (2/92) | 4.78 | 0.002437 | 0.025426 |
GO:0031523 | Myb complex | 2.17% (2/92) | 4.78 | 0.002437 | 0.025426 |
GO:0009057 | macromolecule catabolic process | 10.87% (10/92) | 1.54 | 0.00237 | 0.025466 |
GO:1990542 | mitochondrial transmembrane transport | 3.26% (3/92) | 3.51 | 0.002389 | 0.025485 |
GO:0016887 | ATP hydrolysis activity | 3.26% (3/92) | 3.51 | 0.002389 | 0.025485 |
GO:0002683 | negative regulation of immune system process | 4.35% (4/92) | 2.84 | 0.002426 | 0.025588 |
GO:0003723 | RNA binding | 15.22% (14/92) | 1.23 | 0.00242 | 0.025623 |
GO:0009966 | regulation of signal transduction | 16.3% (15/92) | 1.17 | 0.002416 | 0.025671 |
GO:0051128 | regulation of cellular component organization | 14.13% (13/92) | 1.28 | 0.002492 | 0.0259 |
GO:0006851 | mitochondrial calcium ion transmembrane transport | 2.17% (2/92) | 4.73 | 0.002596 | 0.026403 |
GO:0035114 | imaginal disc-derived appendage morphogenesis | 2.17% (2/92) | 4.73 | 0.002596 | 0.026403 |
GO:0003785 | actin monomer binding | 2.17% (2/92) | 4.73 | 0.002596 | 0.026403 |
GO:0007017 | microtubule-based process | 7.61% (7/92) | 1.92 | 0.002553 | 0.026435 |
GO:0070588 | calcium ion transmembrane transport | 3.26% (3/92) | 3.47 | 0.002575 | 0.026477 |
GO:0010605 | negative regulation of macromolecule metabolic process | 16.3% (15/92) | 1.16 | 0.002567 | 0.026492 |
GO:0098798 | mitochondrial protein-containing complex | 4.35% (4/92) | 2.81 | 0.002615 | 0.026505 |
GO:0007018 | microtubule-based movement | 4.35% (4/92) | 2.81 | 0.002654 | 0.026805 |
GO:0090407 | organophosphate biosynthetic process | 6.52% (6/92) | 2.12 | 0.002703 | 0.027202 |
GO:0016043 | cellular component organization | 28.26% (26/92) | 0.79 | 0.002775 | 0.027534 |
GO:0000159 | protein phosphatase type 2A complex | 2.17% (2/92) | 4.69 | 0.002759 | 0.027571 |
GO:0034440 | lipid oxidation | 3.26% (3/92) | 3.43 | 0.00277 | 0.027582 |
GO:1902531 | regulation of intracellular signal transduction | 8.7% (8/92) | 1.74 | 0.002758 | 0.02766 |
GO:0048856 | anatomical structure development | 32.61% (30/92) | 0.71 | 0.002874 | 0.028417 |
GO:0051641 | cellular localization | 14.13% (13/92) | 1.26 | 0.002909 | 0.028564 |
GO:0006915 | apoptotic process | 3.26% (3/92) | 3.41 | 0.002904 | 0.028622 |
GO:0035120 | post-embryonic appendage morphogenesis | 2.17% (2/92) | 4.64 | 0.002927 | 0.028646 |
GO:0099080 | supramolecular complex | 8.7% (8/92) | 1.73 | 0.002945 | 0.028724 |
GO:0009628 | response to abiotic stimulus | 31.52% (29/92) | 0.72 | 0.003159 | 0.030702 |
GO:0030030 | cell projection organization | 5.43% (5/92) | 2.34 | 0.003201 | 0.031009 |
GO:0071840 | cellular component organization or biogenesis | 29.35% (27/92) | 0.76 | 0.003214 | 0.031027 |
GO:0009059 | macromolecule biosynthetic process | 10.87% (10/92) | 1.47 | 0.003278 | 0.03122 |
GO:0008654 | phospholipid biosynthetic process | 4.35% (4/92) | 2.72 | 0.003289 | 0.031222 |
GO:0004176 | ATP-dependent peptidase activity | 2.17% (2/92) | 4.56 | 0.003277 | 0.031318 |
GO:0140333 | glycerophospholipid flippase activity | 2.17% (2/92) | 4.56 | 0.003277 | 0.031318 |
GO:0044281 | small molecule metabolic process | 19.57% (18/92) | 1.0 | 0.003273 | 0.031491 |
GO:0090304 | nucleic acid metabolic process | 17.39% (16/92) | 1.08 | 0.00336 | 0.031788 |
GO:0048870 | cell motility | 4.35% (4/92) | 2.7 | 0.003474 | 0.032123 |
GO:1902532 | negative regulation of intracellular signal transduction | 5.43% (5/92) | 2.31 | 0.003468 | 0.032174 |
GO:0035307 | positive regulation of protein dephosphorylation | 2.17% (2/92) | 4.52 | 0.003459 | 0.032193 |
GO:0140327 | flippase activity | 2.17% (2/92) | 4.52 | 0.003459 | 0.032193 |
GO:1900101 | regulation of endoplasmic reticulum unfolded protein response | 2.17% (2/92) | 4.52 | 0.003459 | 0.032193 |
GO:0045747 | positive regulation of Notch signaling pathway | 2.17% (2/92) | 4.52 | 0.003459 | 0.032193 |
GO:0045927 | positive regulation of growth | 5.43% (5/92) | 2.31 | 0.003434 | 0.032384 |
GO:0000910 | cytokinesis | 4.35% (4/92) | 2.69 | 0.003521 | 0.032456 |
GO:0044249 | cellular biosynthetic process | 25.0% (23/92) | 0.83 | 0.003562 | 0.032724 |
GO:0045923 | positive regulation of fatty acid metabolic process | 3.26% (3/92) | 3.28 | 0.003717 | 0.034038 |
GO:0007010 | cytoskeleton organization | 7.61% (7/92) | 1.82 | 0.003754 | 0.034265 |
GO:0002244 | hematopoietic progenitor cell differentiation | 2.17% (2/92) | 4.45 | 0.003837 | 0.034911 |
GO:0090068 | positive regulation of cell cycle process | 4.35% (4/92) | 2.64 | 0.003968 | 0.035875 |
GO:1901992 | positive regulation of mitotic cell cycle phase transition | 3.26% (3/92) | 3.25 | 0.00396 | 0.035919 |
GO:0030324 | lung development | 2.17% (2/92) | 4.41 | 0.004033 | 0.036344 |
GO:0044265 | cellular macromolecule catabolic process | 8.7% (8/92) | 1.65 | 0.0041 | 0.036834 |
GO:0002196 | Ser-tRNA(Ala) hydrolase activity | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0070143 | mitochondrial alanyl-tRNA aminoacylation | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0140018 | regulation of cytoplasmic translational fidelity | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0042817 | pyridoxal metabolic process | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0042821 | pyridoxal biosynthetic process | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0032372 | negative regulation of sterol transport | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0032375 | negative regulation of cholesterol transport | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0032378 | negative regulation of intracellular lipid transport | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0032381 | negative regulation of intracellular sterol transport | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0032384 | negative regulation of intracellular cholesterol transport | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0090107 | regulation of high-density lipoprotein particle assembly | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0004815 | aspartate-tRNA ligase activity | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:1900437 | regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:1900439 | positive regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0102867 | molybdenum cofactor sulfurtransferase activity | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:1904481 | response to tetrahydrofolate | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:1904482 | cellular response to tetrahydrofolate | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0008179 | adenylate cyclase binding | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0030989 | dynein-driven meiotic oscillatory nuclear movement | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0007419 | ventral cord development | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0007370 | ventral furrow formation | 1.09% (1/92) | 7.73 | 0.004702 | 0.037197 |
GO:0031328 | positive regulation of cellular biosynthetic process | 14.13% (13/92) | 1.18 | 0.00472 | 0.03724 |
GO:0035306 | positive regulation of dephosphorylation | 2.17% (2/92) | 4.37 | 0.004233 | 0.03779 |
GO:0015996 | chlorophyll catabolic process | 2.17% (2/92) | 4.37 | 0.004233 | 0.03779 |
GO:0006725 | cellular aromatic compound metabolic process | 26.09% (24/92) | 0.79 | 0.004269 | 0.037994 |
GO:0006672 | ceramide metabolic process | 2.17% (2/92) | 4.27 | 0.004861 | 0.038243 |
GO:0051726 | regulation of cell cycle | 8.7% (8/92) | 1.63 | 0.004449 | 0.038748 |
GO:1905476 | negative regulation of protein localization to membrane | 2.17% (2/92) | 4.34 | 0.004438 | 0.038769 |
GO:0006787 | porphyrin-containing compound catabolic process | 2.17% (2/92) | 4.34 | 0.004438 | 0.038769 |
GO:0033015 | tetrapyrrole catabolic process | 2.17% (2/92) | 4.34 | 0.004438 | 0.038769 |
GO:0046149 | pigment catabolic process | 2.17% (2/92) | 4.34 | 0.004438 | 0.038769 |
GO:0030718 | germ-line stem cell population maintenance | 2.17% (2/92) | 4.34 | 0.004438 | 0.038769 |
GO:0003341 | cilium movement | 2.17% (2/92) | 4.34 | 0.004438 | 0.038769 |
GO:0043408 | regulation of MAPK cascade | 4.35% (4/92) | 2.59 | 0.004507 | 0.039137 |
GO:0046907 | intracellular transport | 9.78% (9/92) | 1.5 | 0.004657 | 0.039242 |
GO:0034214 | protein hexamerization | 2.17% (2/92) | 4.3 | 0.004647 | 0.039273 |
GO:0034204 | lipid translocation | 2.17% (2/92) | 4.3 | 0.004647 | 0.039273 |
GO:0097035 | regulation of membrane lipid distribution | 2.17% (2/92) | 4.3 | 0.004647 | 0.039273 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 2.17% (2/92) | 4.3 | 0.004647 | 0.039273 |
GO:0001709 | cell fate determination | 2.17% (2/92) | 4.3 | 0.004647 | 0.039273 |
GO:0032879 | regulation of localization | 11.96% (11/92) | 1.32 | 0.00454 | 0.039303 |
GO:0044089 | positive regulation of cellular component biogenesis | 4.35% (4/92) | 2.55 | 0.005033 | 0.039382 |
GO:0140328 | floppase activity | 2.17% (2/92) | 4.24 | 0.005079 | 0.039417 |
GO:0032147 | activation of protein kinase activity | 2.17% (2/92) | 4.24 | 0.005079 | 0.039417 |
GO:0040018 | positive regulation of multicellular organism growth | 2.17% (2/92) | 4.24 | 0.005079 | 0.039417 |
GO:1990351 | transporter complex | 3.26% (3/92) | 3.13 | 0.005029 | 0.039456 |
GO:0062013 | positive regulation of small molecule metabolic process | 4.35% (4/92) | 2.58 | 0.004621 | 0.039639 |
GO:0051336 | regulation of hydrolase activity | 5.43% (5/92) | 2.21 | 0.004614 | 0.0397 |
GO:0019216 | regulation of lipid metabolic process | 6.52% (6/92) | 1.96 | 0.004605 | 0.03974 |
GO:0050793 | regulation of developmental process | 20.65% (19/92) | 0.9 | 0.005228 | 0.040353 |
GO:0010118 | stomatal movement | 4.35% (4/92) | 2.53 | 0.005217 | 0.040378 |
GO:2000114 | regulation of establishment of cell polarity | 2.17% (2/92) | 4.21 | 0.005302 | 0.040812 |
GO:0009891 | positive regulation of biosynthetic process | 14.13% (13/92) | 1.15 | 0.005454 | 0.041867 |
GO:0019898 | extrinsic component of membrane | 4.35% (4/92) | 2.51 | 0.00547 | 0.041877 |
GO:0043412 | macromolecule modification | 21.74% (20/92) | 0.86 | 0.005649 | 0.043134 |
GO:0010927 | cellular component assembly involved in morphogenesis | 4.35% (4/92) | 2.5 | 0.005664 | 0.043135 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 2.17% (2/92) | 4.15 | 0.005761 | 0.043752 |
GO:0010311 | lateral root formation | 4.35% (4/92) | 2.48 | 0.005864 | 0.044296 |
GO:0006644 | phospholipid metabolic process | 5.43% (5/92) | 2.13 | 0.005856 | 0.044356 |
GO:0000785 | chromatin | 5.43% (5/92) | 2.13 | 0.005906 | 0.044499 |
GO:0002682 | regulation of immune system process | 10.87% (10/92) | 1.35 | 0.005945 | 0.044672 |
GO:0002230 | positive regulation of defense response to virus by host | 2.17% (2/92) | 4.12 | 0.005997 | 0.044945 |
GO:0071248 | cellular response to metal ion | 3.26% (3/92) | 2.95 | 0.007047 | 0.045718 |
GO:0001885 | endothelial cell development | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0061028 | establishment of endothelial barrier | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:1903936 | cellular response to sodium arsenite | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0031569 | mitotic G2 cell size control checkpoint signaling | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0061246 | establishment or maintenance of bipolar cell polarity regulating cell shape | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0097575 | lateral cell cortex | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0120105 | mitotic actomyosin contractile ring, intermediate layer | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:1902472 | regulation of mitotic cytokinesis, site selection | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:1903137 | regulation of cell wall integrity MAPK cascade | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:1903138 | negative regulation of cell wall integrity MAPK cascade | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:1903617 | positive regulation of mitotic cytokinesis, site selection | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:2000073 | regulation of cytokinesis, site selection | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:2000076 | positive regulation of cytokinesis, site selection | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0004813 | alanine-tRNA ligase activity | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0006419 | alanyl-tRNA aminoacylation | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0010872 | regulation of cholesterol esterification | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0032377 | regulation of intracellular lipid transport | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0032380 | regulation of intracellular sterol transport | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0032383 | regulation of intracellular cholesterol transport | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0004046 | aminoacylase activity | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0000717 | nucleotide-excision repair, DNA duplex unwinding | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0032289 | central nervous system myelin formation | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0043249 | erythrocyte maturation | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0045951 | positive regulation of mitotic recombination | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0002813 | regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0006964 | positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0045744 | negative regulation of G protein-coupled receptor signaling pathway | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0048264 | determination of ventral identity | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0005757 | mitochondrial permeability transition pore complex | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0097002 | mitochondrial inner boundary membrane | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:1902686 | mitochondrial outer membrane permeabilization involved in programmed cell death | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0004816 | asparagine-tRNA ligase activity | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0052813 | phosphatidylinositol bisphosphate kinase activity | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:1902633 | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:1902635 | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 1.09% (1/92) | 7.15 | 0.007045 | 0.045806 |
GO:0031349 | positive regulation of defense response | 7.61% (7/92) | 1.69 | 0.006149 | 0.045961 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 2.17% (2/92) | 4.09 | 0.006237 | 0.04614 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 2.17% (2/92) | 4.09 | 0.006237 | 0.04614 |
GO:1903725 | regulation of phospholipid metabolic process | 2.17% (2/92) | 4.09 | 0.006237 | 0.04614 |
GO:0098609 | cell-cell adhesion | 2.17% (2/92) | 4.09 | 0.006237 | 0.04614 |
GO:0030036 | actin cytoskeleton organization | 3.26% (3/92) | 2.94 | 0.007165 | 0.046376 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.43% (5/92) | 2.06 | 0.007201 | 0.046505 |
GO:0140030 | modification-dependent protein binding | 3.26% (3/92) | 2.93 | 0.007284 | 0.046932 |
GO:1901576 | organic substance biosynthetic process | 25.0% (23/92) | 0.75 | 0.007392 | 0.047412 |
GO:0022411 | cellular component disassembly | 4.35% (4/92) | 2.39 | 0.00739 | 0.047507 |
GO:0017025 | TBP-class protein binding | 2.17% (2/92) | 4.06 | 0.006482 | 0.047579 |
GO:0008525 | phosphatidylcholine transporter activity | 2.17% (2/92) | 4.06 | 0.006482 | 0.047579 |
GO:0061134 | peptidase regulator activity | 3.26% (3/92) | 2.99 | 0.006476 | 0.047784 |
GO:0140303 | intramembrane lipid transporter activity | 2.17% (2/92) | 3.95 | 0.007504 | 0.047809 |
GO:0006476 | protein deacetylation | 2.17% (2/92) | 3.95 | 0.007504 | 0.047809 |
GO:0003680 | minor groove of adenine-thymine-rich DNA binding | 2.17% (2/92) | 3.95 | 0.007504 | 0.047809 |
GO:1901989 | positive regulation of cell cycle phase transition | 3.26% (3/92) | 2.98 | 0.006588 | 0.048234 |
GO:1901360 | organic cyclic compound metabolic process | 27.17% (25/92) | 0.72 | 0.006656 | 0.048608 |
GO:0004222 | metalloendopeptidase activity | 2.17% (2/92) | 4.03 | 0.006731 | 0.048655 |
GO:0032370 | positive regulation of lipid transport | 2.17% (2/92) | 4.03 | 0.006731 | 0.048655 |
GO:0050691 | regulation of defense response to virus by host | 2.17% (2/92) | 4.03 | 0.006731 | 0.048655 |
GO:0009792 | embryo development ending in birth or egg hatching | 4.35% (4/92) | 2.43 | 0.006707 | 0.048852 |
GO:0016874 | ligase activity | 4.35% (4/92) | 2.42 | 0.006781 | 0.048889 |
GO:0019048 | modulation by virus of host process | 2.17% (2/92) | 3.92 | 0.00777 | 0.049394 |
GO:0006816 | calcium ion transport | 3.26% (3/92) | 2.96 | 0.006931 | 0.04972 |
GO:0016050 | vesicle organization | 4.35% (4/92) | 2.41 | 0.00693 | 0.049837 |
GO:0010035 | response to inorganic substance | 18.48% (17/92) | 0.91 | 0.007857 | 0.049838 |
GO:0140326 | ATPase-coupled intramembrane lipid transporter activity | 2.17% (2/92) | 4.0 | 0.006984 | 0.049853 |
GO:0016575 | histone deacetylation | 2.17% (2/92) | 4.0 | 0.006984 | 0.049853 |
GO:0019866 | organelle inner membrane | 4.35% (4/92) | 2.41 | 0.007005 | 0.049875 |